Death of TB Champion, Rep. Donald Payne

5 Mar 2012
by Working Group

U.S. Representative Donald Payne (D-NJ)

Statement from RESULTS:

RESULTS Mourns the Death of Rep. Donald Payne

Joanne Carter, Executive Director of RESULTS/RESULTS Educational Fund, issued the following statement:

RESULTS is saddened to learn of the death of Representative Donald Payne, who was a true champion for global health and fighting poverty, particularly in Africa.

As chair and ranking member of the Africa and Global Health Subcommittee, Rep. Payne was an outspoken advocate in the fight against AIDS, tuberculosis, malaria, and other diseases of poverty. His bold leadership was particularly instrumental in increasing funding to combat tuberculosis, the leading killer of people living with HIV/AIDS in sub-Saharan Africa.

Rep. Payne was a steadfast supporter of access to microfinance and education for the very poor, agriculture and nutrition programs to fight hunger, and efforts to bring peace and justice to countries and people in crisis.

We will remember his passionate commitment to these issues. His tireless leadership will be truly missed.

On behalf of RESULTS members in New Jersey and across the country, we extend our sympathies to his family, friends, staff, and colleagues for their loss.

Additional Coverage:

Rep. Donald Payne’s Biography

Donald M. Payne, First Black Elected to Congress From New Jersey, Dies at 77

Rep. Donald Payne of New Jersey dies at age 77 (FOX)

Congressman Donald M. Payne Dead at 77 (Patch)

More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...